首页 › 基金 › Kynam Capital Management, LP › PHVS
Kynam Capital Management, LP 对 PHVS 的持仓历史
PHARVARIS N V · 医疗保健
Kynam Capital Management, LP 在 Q2 2026 的 13F 申报中披露持有 PHVS(PHARVARIS N V)661,795 股,市值约 US$22.9M,约占其申报组合的 1.26%,在其申报持仓中市值排名第 19 位。 Kynam Capital Management, LP 最近 4 个申报季度中有 4 个季度披露了 PHVS 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Kynam Capital Management, LP 对 PHVS 的持仓演变
Kynam Capital Management, LP 于 Q3 2025 首次披露 PHVS 持仓:675,000 股(约 US$16.8M)。 该持仓在 Q2 2026 达到峰值 661,795 股,市值约 US$22.9M。 在 4 次申报中,Kynam Capital Management, LP 1 次增持、1 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 661,795 股、市值约 US$22.9M,环比增持 21,400 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 675.00K | $16.84M | 新进 |
| Q4 2025 | 640.39K | $17.77M | 减持 |
| Q1 2026 | 640.39K | $18.09M | 持有 |
| Q2 2026 | 661.79K | $22.88M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PHVS 与 13F 数据
PHVS(PHARVARIS N V)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 PHVS,申报仓位最大的包括:GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PHVS 的基金
- GENERAL ATLANTIC, L.P. 6.55M 股 · $226.53M · Q2 2026
- Foresite Capital Management IV, LLC 4.78M 股 · $165.24M · Q2 2026
- venBio Partners LLC 4.64M 股 · $160.57M · Q2 2026
- EQT Fund Management S.a r.l. 3.42M 股 · $118.42M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.38M 股 · $116.74M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.68M 股 · $92.52M · Q2 2026
- Commodore Capital LP 1.43M 股 · $49.28M · Q2 2026
- Novo Holdings A/S 1.40M 股 · $48.41M · Q2 2026
- Saturn V Capital Management LP 1.31M 股 · $45.44M · Q2 2026
- TCG Crossover Management, LLC 1.01M 股 · $34.86M · Q2 2026
- Sofinnova Investments, Inc. 881.30K 股 · $30.48M · Q2 2026
- 5AM Venture Management, LLC 797.60K 股 · $27.58M · Q2 2026
更多关于 Kynam Capital Management, LP
常见问题
How long has Kynam Capital Management, LP held PHVS?
Kynam Capital Management, LP has disclosed PHVS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Kynam Capital Management, LP's current position in PHVS?
As of Q2 2026, Kynam Capital Management, LP holds 661.79K shares of PHVS (PHARVARIS N V), valued at $22.88M, representing 1.26% of its reported portfolio and ranking #19.
Has Kynam Capital Management, LP been buying or selling PHVS?
In the latest 13F filing (Q2 2026), Kynam Capital Management, LP increased its position in PHVS. The position peaked in Q2 2026 at 661.79K shares.
Which other funds hold PHVS?
Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.